Hiroyuki Suzuki

Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)

Tohru Kobayashi, Mamoru Ayusawa, Hiroyuki Suzuki et al. · Pediatrics International · 2020 · 584 citations

Clinical Epidemiology, Diagnosis, Pathology +3

A genome-wide association study identifies three new risk loci for Kawasaki disease

Yoshihiro Onouchi, Kouichi Ozaki, Jane C. Burns et al. · Nature Genetics · 2012 · 334 citations

Genome-wide Association Study, Disease Susceptibility, Medicine +10

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiromichi Hamada, Hiroyuki Suzuki, Yoshihiro Onouchi et al. · The Lancet · 2019 · 202 citations

Cardiovascular Disease, Atherosclerosis, Intravenous Immunoglobulin +7

Common variants in CASP3 confer susceptibility to Kawasaki disease

Yoshihiro Onouchi, Kouichi Ozaki, Jane C. Buns et al. · Human Molecular Genetics · 2010 · 174 citations · Full text

Immunodeficiencies, Genetics, Genetic Epidemiology +16

Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin

Hiroyuki Suzuki, Masaru Terai, Hiromichi Hamada et al. · The Pediatric Infectious Disease Journal · 2011 · 154 citations